Christoph Nienaber | Cardiovascular Medicine | Excellence in Academia Award

Published on by Global Academic Awards

Excellence in Academia Award

Christoph Nienaber
Affiliation Royal Brompton and Harefield Hospitals
Country United Kingdom
Scholar ID pWDqkeQAAAAJ
Documents 1435
Citations 76,690
h-index 121
Subject Area Physical Activity
Event Global Academic Awards

Christoph Nienaber
Royal Brompton and Harefield Hospitals

Christoph Nienaber has established an internationally recognized academic profile through an extensive publication record, substantial citation impact, and continued contributions to cardiovascular medicine and clinical research. His scholarly influence is reflected through widely cited publications, interdisciplinary collaboration, and long-term engagement in evidence-based medical science.[1]

Abstract

Christoph Nienaber has developed an extensive academic career characterized by high-impact research, broad international collaboration, and significant scientific influence. Bibliometric indicators, including more than 1,400 indexed publications, over 76,000 citations, and an h-index exceeding one hundred, demonstrate sustained scholarly productivity and lasting academic impact. These indicators support recognition for long-term excellence in research and higher education.[1]

Keywords

  • Academic Excellence
  • Cardiovascular Medicine
  • Clinical Research
  • Evidence-Based Medicine
  • Scientific Leadership
  • Research Impact

Introduction

Academic excellence encompasses sustained scientific productivity, innovation, mentorship, and contributions that influence research, education, and clinical practice. Recognition through academic awards acknowledges individuals whose scholarly achievements have advanced knowledge within their respective disciplines and contributed to global scientific development.[2]

Research Profile

Christoph Nienaber is affiliated with Royal Brompton and Harefield Hospitals in the United Kingdom. His Google Scholar profile reports approximately 1,435 scholarly publications, over 76,690 citations, and an h-index of 121. These bibliometric measures illustrate exceptional academic productivity and a substantial influence on contemporary cardiovascular research.[1]

Research Contributions

  • Advancement of cardiovascular medicine and clinical cardiology.
  • Leadership in translational and evidence-based clinical research.
  • Extensive peer-reviewed scientific publications.
  • International collaboration and multidisciplinary research initiatives.
  • Contribution to clinical guidelines and medical education.

Publications

The researcher’s publication portfolio spans cardiovascular medicine, vascular diseases, clinical imaging, intervention, and translational healthcare research. Numerous articles have appeared in internationally recognized peer-reviewed journals and continue to receive substantial scholarly citations.[1]

Research Impact

High publication output combined with extensive citation performance demonstrates enduring scientific influence. The researcher’s work has contributed to clinical decision-making, medical education, and continued advancement of cardiovascular science through internationally recognized scholarly communication.[1]

Award Suitability

Based on publicly available bibliometric indicators and documented scholarly achievements, Christoph Nienaber demonstrates the characteristics commonly associated with recipients of academic excellence awards, including sustained publication productivity, exceptional citation impact, international scientific visibility, and long-term contributions to research and higher education. Final award determinations remain subject to independent evaluation by the awarding organization.[3]

Conclusion

Christoph Nienaber’s extensive scholarly record reflects sustained academic excellence, influential research, and meaningful contributions to cardiovascular medicine. His long-standing commitment to scientific inquiry, publication, and international collaboration illustrates the qualities recognized through the Excellence in Academia Award.

References

  1. Google Scholar. (n.d.). Author profile: Christoph Nienaber.
    https://scholar.google.com/citations?user=pWDqkeQAAAAJ&hl=en&oi=sra
  2. Aortic Diameter ≥5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD).
    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.107.702720
  3. Randomized Comparison of Strategies for Type B Aortic Dissection: The INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) Trial.
    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.109.886408

 

Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

Published on by Global Academic Awards

Prof. Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

University of Bari Aldo Moro | Italy

Prof. Vincenzo Ezio Santobuono is an accomplished cardiologist and academic with a Classical High School Diploma (1999), a Degree in Medicine and Surgery from the University of Bari (2006, summa cum laude), a Specialization in Cardiology (2011, summa cum laude), and a PhD in Experimental and Forensic Medicine and Pathology (2015). He has built a distinguished career combining clinical expertise, academic leadership, and pioneering research in cardiology, particularly in telecardiology, remote monitoring, arrhythmia management, and cardiac resynchronization therapy. Professionally, he has served as Medical Director at the Regional TeleCardiology Center of Bari, specialist consultant for military and governmental institutions, and lecturer at the University of Bari “Aldo Moro” across nursing, medicine, radiology, psychiatric rehabilitation, and cardiovascular disease programs. Currently, he is a fixed-term researcher (RTD-A) leading an innovative project on telecardiology integration within hospital-territory networks. His academic impact is reflected in Scopus metrics with 502 citations, 52 indexed documents, and an h-index of 11, alongside numerous high-impact publications and a patent on supraventricular arrhythmia treatment. Fluent in English and Italian, he actively contributes to cardiovascular innovation, bridging advanced clinical practice with technological solutions to improve patient-centered care and healthcare delivery.

Profile: Scopus | Orcid

Featured Publications

  • Santobuono, V. E., et al. (2025). NPPA-associated atrial dilated cardiomyopathy: Genotypic and phenotypic insights from an ultrarare inherited disorder.

  • Santobuono, V. E., et al. (2025). Differentiating sensor changes in a composite heart failure ICD monitoring index: Clinical correlates and implications.

  • Santobuono, V. E., et al. (2025). Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis. International Journal of Cardiology.

  • Santobuono, V. E., et al. (2025). Kinetics of procalcitonin, CRP, IL-6, and presepsin in heart transplant patients undergoing induction with thymoglobulin (rATG). Journal of Clinical Medicine.

  • Santobuono, V. E., et al. (2025). Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

Vahid Eslami | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran

Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). 🏥 As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. 🎓 A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.

Publication Profile

Google Scholar

Professional Experience

Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. 📈 He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. 🏥 As a medical educator, he has trained over 100 cardiology residents and fellows. 🧑‍⚕️ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍

🎓 Education & Medical Training

Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. 🏅 He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. 🫀 He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. 📘 His training solidified his expertise in advanced cardiovascular care and research

🏅 Licenses & Certifications

Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) 🎓. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.

🧠🔬 Research Focus

Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology

Publication Top Notes

  • 📄 Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – 📊738 citations | 📅2021

  • 📄 Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – 📊87 citations | 📅2022

  • 📄 Atorvastatin versus placebo in patients with covid-19 in intensive care… – 📊76 citations | 📅2022

  • 📄 Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – 📊61 citations | 📅2013

  • 📄 Association of CT-measured cardiac indices with lung involvement in COVID-19 – 📊48 citations | 📅2021

  • 📄 Are women more susceptible to ischemic heart disease? A literature overview – 📊36 citations | 📅2021

  • 📄 Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – 📊31 citations | 📅2021

  • 📄 Extrinsic compression of left main coronary artery by the pulmonary trunk… – 📊28 citations | 📅2009

  • 📄 Management of STEMI during COVID-19: Iranian “247” National Committee’s position paper – 📊26 citations | 📅2021

  • 📄 Prognostic value of inflammatory biomarkers in COVID-19 patients – 📊15 citations | 📅2021

Guanwei Fan | Cardiovascular research | Best Researcher Award

Published on by Global Academic Awards

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes  

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖

 

 

 

Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Dr. Xiangxiang Zheng, Jiangsu Province Hospital, China

Dr. Xiangxiang Zheng, a dedicated cardiac surgeon at Jiangsu Provincial People’s Hospital since 2008, specializes in minimally invasive treatments for heart valve diseases and stem cell therapy for myocardial infarction. With a PhD and over 300 cardiac surgeries performed annually, he is at the forefront of cardiovascular innovation. His notable publications include research on engineering extracellular vesicles for diagnosis and therapy, and comparing surgical techniques for atrial septal defect repair. Dr. Zheng’s work significantly contributes to advancing surgical practices and improving patient outcomes. He is 42 years old and married. ❤️👨‍⚕️📚

 

Publication profile

Scopus


Professional Experience

Since 2008, Dr. Xiangxiang Zheng has been an esteemed cardiac surgeon in the Department of Cardiovascular Surgery at Jiangsu Provincial People’s Hospital. With over 300 cardiac surgeries performed annually, he has established himself as a leader in the field. Dr. Zheng specializes in minimally invasive treatments for heart valve diseases, which significantly reduce recovery time and improve patient outcomes. His expertise also extends to stem cell therapy for myocardial infarction, where he employs innovative techniques to enhance heart repair and regeneration. Dr. Zheng’s dedication to advancing cardiovascular care is evident through his hands-on surgical practice and commitment to exploring new methodologies in cardiac surgery. He continuously strives to improve surgical techniques and patient safety, making a lasting impact on the lives of those he treats. His contributions not only elevate the standard of care in his department but also serve as an inspiration to his colleagues and the medical community. 🌟👨‍⚕️📈

 

Research Focus

Dr. Xiangxiang Zheng’s research primarily focuses on cardiovascular surgery, particularly in innovative surgical techniques and therapies for heart diseases. His work emphasizes minimally invasive procedures, such as thoracoscopic surgeries for atrial septal defect repair, as well as advanced myocardial protection strategies during complex cardiac surgeries. Additionally, Dr. Zheng explores stem cell therapy and the engineering of extracellular vesicles for therapeutic applications, enhancing diagnosis and treatment methods in cardiology. His research also delves into the physiological impacts of surgical interventions on heart function and the progression of pulmonary arterial hypertension, contributing significantly to the field of cardiovascular medicine. 🏥📚✨

 

Publication Top Notes

  • Engineering extracellular vesicles for diagnosis and therapy 🧬
    Fei, Z., Zheng, J., Zheng, X., Ren, H., Liu, G.
    Trends in Pharmacological Sciences, 2024.
    Cited by: 0
  • The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats 🐭
    Liu, W., Men, C., Liu, Z., Zhang, L., Zheng, X.
    Journal of Physiological Investigation, 2024, 67(4), pp. 207-214.
    Cited by: 0
  • Triport Periareolar Thoracoscopic Surgery versus Right Minithoracotomy for Repairing Atrial Septal Defect in Adults 💔
    Zheng, X.-X., Wang, Z.-Y., Ma, L.-Y., Qin, J.-W., Shao, Y.-F.
    Interactive Cardiovascular and Thoracic Surgery, 2021, 32(2), pp. 313-318.
    Cited by: 5
  • Comparison of Myocardial Protection Effect between Del Nido Cardioplegia and Cold Blood Cardioplegia in Complex Cardiac Surgery 💉
    Jiao, S.-Y., Liu, L., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2020, 33(6), pp. 807-810.
    Cited by: 0
  • Myocardial Protective Effect of Three Cardioplegia in Adult Valve Replacement 💗
    Liu, H., Jiao, S.-Y., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2019, 32(6), pp. 775-778.
    Cited by: 1
  • Bilateral Superior Cervical Ganglionectomy Attenuates the Progression of β-Aminopropionitrile-induced Aortic Dissection in Rats 🧪
    Liu, H., Zheng, X., Zhang, L., Shao, Y., Zhang, S.
    Life Sciences, 2018, 193, pp. 200-206.
    Cited by: 5
  • Cardiac Autotransplantation for Repair of Left Ventricular Rupture after Mitral Valve Replacement 🏥
    Ni, B., Zheng, X., Zhang, S., Shao, Y.
    Interactive Cardiovascular and Thoracic Surgery, 2017, 25(1), pp. 150-152.
    Cited by: 3
  • Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma 🔬
    Hu, H.-B., Jie, H.-Y., Zheng, X.-X.
    Cellular Physiology and Biochemistry, 2016, 40(1-2), pp. 117-125.
    Cited by: 68
  • High Expression of LncRNA PVT1 Promotes Invasion by Inducing Epithelial-to-Mesenchymal Transition in Esophageal Cancer 🚀
    Zheng, X., Hu, H., Li, S.
    Oncology Letters, 2016, 12(4), pp. 2357-2362.
    Cited by: 85
  • Myxoid Fibrosarcoma of the Left Atrium and Ventricle in Pregnancy 👶❤️
    Zhang, W., Zheng, X., Ni, B., Shao, Y., Zhang, S.
    Annals of Thoracic Surgery, 2014, 98(5), pp. 1818-1819.
    Cited by: 3

Jae Hoon Lee | electrocardiography Award | Best Researcher Award

Published on by Global Academic Awards

 Prof Dr.Jae Hoon Lee | electrocardiography Award | Best Researcher Award

 Prof Dr. Jae Hoon Lee, Dong-A university hospital, South Korea

Dr. Jae Hoon Lee is a distinguished medical professional affiliated with Dong-A University Hospital in South Korea. With expertise in his field, Dr. Lee has made significant contributions to the advancement of healthcare through his research, clinical practice, and academic pursuits. He is highly regarded for his dedication to patient care and his commitment to education, training, and mentoring the next generation of healthcare professionals. Dr. Lee’s work exemplifies excellence in medicine and underscores his unwavering passion for improving the health and well-being of individuals and communitie

 

Publication Profile :

Scopus

Education and Training:

MD: Dong-A University College of Medicine, Busan, Korea,Master’s in Medicine: Dong-A University College of Medicine, Busan, Korea,Doctor’s Medicine: Busan University College of Medicine, Busan, Korea

Professional Experience :

Full Professor: Department of Emergency Medicine, Dong-A University Hospital, Busan, Korea (2024.3.1~ present),Associate Professor: Department of Emergency Medicine, Dong-A University Hospital, Busan, Korea (2019.3.1~2023.2.28),Assistant Professor: Department of Emergency Medicine, Dong-A University Hospital, Busan, Korea (2013.3.1~2018.2.28),Clinical Professor: Department of Emergency Medicine, Dong-A University Hospital, Busan, Korea (2011.3.1~2013.2.28),Emergency Medicine Specialist (Acquisition): Seoul ST. Mary’s Hospital (2009.3.1~ 2011.2.28),Internal Medicine Specialist (Acquisition): Busan Dong-A Hospital (2005.5.1~ 2009.2.28)

 

Publication Top Notes :

  • Publication Date: February 2024
  • Journal: Annals of Noninvasive Electrocardiology
  • Authors: Jae Hoon Lee

2. A Novel Tool for Distinguishing Type A Acute Aortic Syndrome from Heart Failure and Acute Coronary Syndrome

  • Publication Date: November 2023
  • Journal: Diagnostics
  • Authors: Min Joon Seo, Jae Hoon Lee, and Yang-Weon Kim

3. Early Neuroprognostication Using Frontal Spectrograms in Moderately Sedated Cardiac Arrest Patients

  • Publication Date: May 2023
  • Authors: Jae Hoon Lee

4. Prediction of disorders with significant coronary lesions using machine learning in patients admitted with chest symptom

  • Publication Date: October 2022
  • Journal: Plos One
  • Authors: Jae Young Choi, Jae Hoon Lee, Yuri Choi, YunKyong Hyon, Yong Hwan Kim

5. Heart rate and diastolic arterial pressure in cardiac arrest patients: A nationwide, multicenter prospective registry

  • Publication Date: September 2022
  • Journal: Plos One
  • Authors: Chul Han, Jae Hoon Lee, on behalf of the Korean Hypothermia Network Investigators

6. The effects of patient positioning on hemodynamic parameters

  • Publication Date: August 2022
  • Journal: Signa Vitae
  • Authors: Ju Hong Lee, Jae Hoon Lee

7. Neurological Prognostication Using Raw EEG Patterns and Spectrograms of Frontal EEG in Cardiac Arrest Patients

  • Publication Date: July 2022
  • Journal: Journal of Clinical Neurophysiology
  • Authors: Wook Jin Choi, Jae Hoon Lee, and Sang Ho Kim

8. Dynamic changes in electrocardiographic findings between initial and follow-up electrocardiography: The role of the T/QRS ratio

  • Publication Date: April 2022
  • Journal: American Journal of Emergency Medicine
  • Authors: Yuri Choi, Jae Hoon Lee

David Song | Cardiovascular Disease | Excellence in Research

Published on by Global Academic Awards

Dr. DavidSong | Cardiovascular Disease | Excellence in Research

Dr. DavidSong, Icahn School of Medicine at Mount Sinai Elmhurst, United States

Dr. David Song is a dedicated cardiologist with extensive medical training and a passion for education and research. He earned his Doctorate of Osteopathic Medicine from Rowan University and completed his Internal Medicine Residency at Icahn School of Medicine. Dr. Song’s accolades include awards for teaching, research, and professionalism. As an Executive Chief Resident, he demonstrated leadership at ISMMS/Elmhurst. Beyond medicine, Dr. Song is a Black Belt in Korean Kumdo and has a history of community service. His commitment extends to mentoring, tutoring, and various leadership roles. 🩺🏆📚

Publication Profile:

Scopus 

Orcid

Education:

Dr. David Song’s academic journey reflects a profound commitment to medical excellence. Beginning with a Bachelor of Science in Neuroscience from Stony Brook University, where he graduated with honors, Magna Cum Laude, Dr. Song continued to Rowan University for his Doctorate of Osteopathic Medicine. He further honed his skills through an Internal Medicine Residency at Icahn School of Medicine, followed by a Chief Residency. Currently, he is pursuing a Clinical Fellowship in Cardiovascular Disease at New York Presbyterian/Queens. Dr. Song’s educational odyssey embodies a relentless pursuit of knowledge and expertise in cardiovascular health. 🩺

Honors and Awards:

Dr. David Song stands as a beacon of academic excellence, adorned with numerous accolades throughout his educational journey. His achievements include being recognized as Internal Medicine PGY-3 Resident Teacher and Resident of the Year at Icahn School of Medicine. Dr. Song’s dedication to research earned him the First Place Research Poster Award and membership in the prestigious Alpha Omega Alpha Honor Medical Society. Notably, he received the Doximity Most Cited Research and Top Published Research Awards, showcasing his impact in the medical field. Beyond academics, his commitment to community service is exemplified by scholarships, leadership awards, and extensive involvement in medical missions. 🏆👨‍⚕️

Work Experience:

Dr. David Song’s multifaceted career includes serving as the Executive Chief Resident at ISMMS/Elmhurst, showcasing his leadership in medical education. His commitment extends to mentorship through the Central Academic Assistance Program at Central Presbyterian Church, where he imparted knowledge to high school students. Dr. Song’s research expertise shines through his role as a Clinical Research Coordinator at Penn Medicine, where he contributed to therapeutic lipid-lowering drug development. His dedication to education continued as a Peer Tutor at Rowan SOM and Head Instructor at Plainview Summer School. Beyond academia, Dr. Song’s analytical skills were honed as an Analytical Chemist, and he contributed significantly as a Research Assistant at Stony Brook University. 🌐👨‍🏫

Research Focus:

Dr. David Song, a distinguished researcher in cardiovascular medicine, has made significant contributions to the field through a prolific body of work. His research focuses on diverse topics, ranging from the intricacies of mitral regurgitation in heart failure to meta-analyses comparing different percutaneous coronary interventions. Dr. Song collaborates with esteemed colleagues, consistently publishing in reputable journals such as Radiology Case Reports and The American Journal of Cardiology. His dedication to unraveling complex medical scenarios, including the impact of COVID-19 on cardiovascular outcomes, showcases a commitment to advancing medical knowledge. 📊🔬

Publication Top Notes:

Ortner syndrome as a presenting symptom of severe chronic mitral regurgitation in heart failure: A case report

Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis

A case report of multiple abscesses caused by Streptococcus intermedius

RETRACTED: Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: A meta-analysis

Too much of a good thing: Immune reconstitution inflammatory syndrome in a patient with Still’s disease

Meta-Analysis Comparing Distal Radial Versus Traditional Radial Percutaneous Coronary Intervention or Angiography

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis

A rare case of delayed anaplasma phagocytophilum-induced pancytopenia: A diagnostic conundrum

Meta-Analysis Comparing Gender-Based Cardiovascular Outcomes of Transradial Versus Transfemoral Access of Percutaneous Coronary Intervention

Curing the incurable: A case of refractory vasospastic angina